Table 1.
Clinical and laboratory characteristics of the study group (27 patients)
| Frequency | Percent | |
|---|---|---|
| Laboratory data | ||
| CBC parameters | ||
| Anemia | 17 | 63.00 |
| Thrombocytopenia < 150 × 103 | 6 | 22.20 |
| Leukocytosis | 16 | 59.30 |
| Lymphopenia < 1000/ccm3 | 14 | 51.90 |
| Hypernatremia > 45 mEq/L | 14 | 51.90 |
| K disturbances | ||
| Low | 6 | 22.20 |
| High | 10 | 37.00 |
| Metabolic acidosis (ph < 7.2) | 12 | 44.40 |
| High CRP > 5 mg/dl | 27 | 100.00 |
| High ferritin > 200 mg/dl) | 27 | 100.00 |
| High d- dimer > 500 mg/dl | 17 | 63.00 |
| Coagulopathy (INR > 1.2) | 13 | 48.10 |
| High troponin I (> 100 pg/mI) | 6 | 22.20 |
| Complications | ||
| Pneumonia | 18 | 66.70 |
| ARDS | 5 | 18.50 |
| AKI (eGFR < 60 ml/min/m2) | 10 | 37.00 |
| Myocarditis | 6 | 22.20 |
| Medications | ||
| Vasoactive infusion | 8 | 29.60 |
| Antibiotics | 26 | 96.30 |
| Corticosteroids | 22 | 81.50 |
| Anticoagulants | 14 | 51.80 |
| Antiplatelets | 17 | 63.00 |
| Remdesivir | 1 | 4.00 |
| IVIG | 4 | 14.80 |
| Outcomes | ||
| Discharge | 23 | 85.20 |
| Mortality | 4 | 14.80 |
AKI, acute kidney injury; ARDS, acute respiratory distress syndrome; CBC, complete blood counts; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; INR, international normalization ratio; IVIG, intravenous immunoglobulins; K, potassium